Biomarkers in Prediction of AMI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarkers in Prediction of AMI — Stella

Home/Acute Mesenteric Ischemia/

View on ClinicalTrials.gov

Recruiting

Back to Acute Mesenteric Ischemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Estonia

Tartu University Hospital, Tartu

Switzerland

Lucerne Cantonal Hospital, Lucerne

Key details

Sponsor

University of Tartu

Enrollment target

~250 participants

Started

October 2024

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.